In Vivo Facility Welcomes Matt Bernard and Heidi Ball

The Invivo Facility is pleased to bid ~ Matt Bernard, PhD, and Heidi Ball, BS, to our laboratory.

Matt, an immunotoxicologist, comes to the In Vivo Facility from Bristol-Myers Squibb at which place he worked in Drug Safety Evaluation performing investigative investigation for small molecules and biologics in a GLP environment. He admitted his PhD in Microbiology & Immunology from the University of Rochester in which place he characterized the role that the incendiary mediator, cyclooxygenase-2, plays in pathogen- and vaccination-elicited B small room immunity. Matt continued his training while a postdoctoral fellow at the La Jolla Institute in favor of Allergy & Immunology before joining the Immunotoxicology team at Bristol-Myers Squibb. He has specialized in immunoassay evolution, validation, and implementation for pharmacology and toxicology studies, and has a wealth of move along easily cytometry experience. Matt brings his extensive knowledge in designing and conducting applied examination studies in immunopharmacology and immunotoxicology to widen our current expertise here at MSU’s In Vivo Facility.

Heidi Ball is each experienced researcher in companion animal investigations and in veterinary clinical trials. She comes from the Department of Oncology at the Michigan State University Veterinary Medical Center in which place she focused on tumor tissue banking and GCP veterinary clinical trials. Most newly she served as Study Coordinator beneficial to the VMC Open Heart Surgery cluster under the direction of Dr. Augusta Pelosi, with research emphasis on mitral valve form, degeneration, and repair. Heidi’s interests comprehend the design, coordination and conduct of veterinary clinical trials and the study of cardiovascular ail. She received her BS in Biology from Grand Valley State University.

About these ads

Many adults and strange to say some children have high blood straits.

Both comments and pings are currently closed.